Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
triple-negative breast cancer
Pharma
Kelun's Merck-partnered TROP2 ADC snags first nod in China
Sacituzumab tirumotecan's China nod in triple-negative breast cancer matches the 2022 blessing that Trodelvy secured from regulators in the country.
Angus Liu
Nov 27, 2024 10:56am
Gilead supports ‘sanctuary’ for Black breast cancer patients
Nov 20, 2024 11:36am
Merck's Keytruda helps early-stage TNBC patients live longer
Sep 15, 2024 8:10am
AstraZeneca stands by Truqap despite surprise breast cancer flop
Sep 13, 2024 10:00am
Merck, AstraZeneca, Gilead: The race for supremacy in an ADC field
Aug 2, 2024 4:00pm
AZ's Truqap came up short in triple-negative breast cancer study
Jun 18, 2024 9:09am
